Steve Lloyd

Principal Research Leader, Analytical Chemistry

Steve Lloyd is a highly-experienced analytical chemist who leads the Domainex Analytical Team. Previously he was a Principal Analytical Scientist for over 8 years in the Analytical Research and Development group at UCB R&D (formally Celltech Chiroscience) and was responsible for the development of numerous analytical methods in support of pre-clinical and clinical candidates. Prior to this he worked at Pfizer, Sandwich, as an analytical scientist in the Analytical R&D department.

 

With nearly 25 years’ experience in drug discovery, Steve has worked on a number of different R&D projects and a range of biological targets including; Der p 1 protease, TANK-binding kinase 1 (TBK1) IkappaB kinase epsilon (IKKε), phosphoinositide 3 kinase (PI3K), matrix metalloproteinases (MMP), interleukin-1 receptor associated kinase (IRAK), inosine 5'-monophosphate dehydrogenase (IMPDH), Inositol-1-phosphatase, P2Y2 receptors, PPIs, phosphodiesterase IV (PDE IV) and phosphodiesterase VII (PDE VII) inhibitors as well as a number of protein-protein interaction targets.